Improving Translational Research and Clinical Trials with Digital Pathology

Biotech, Clinical Trials, Drug Discovery & Development, Life Science, Pharma,
  • Wednesday, November 05, 2025

Pathology plays a decisive role in translational research and clinical trials, yet it is often a source of inconsistency, delay and uncertainty.

Multiple vendors, variable scoring and limited access to subspecialist expertise can undermine data quality, slow down timelines and add regulatory risk.

In fact, the majority of translational programmes fail to progress to trials, and nearly 90% of clinical trial drugs never reach approval.

Join this webinar to learn how expert-led, digitally enabled pathology can turn these challenges into opportunities for sponsors and CROs.

The featured speakers will explore how embedding subspecialist pathology expertise into study workflows provides clarity at every stage, from protocol design and endpoint definition to centralised review and CRO oversight.

Discussions will include the impact of aligned pathology strategy on study efficiency and the advantages of streamlined decision-making across teams. The session will also consider how virtual tools extend specialist access beyond geographic and institutional constraints.

Register for this webinar to learn how expert-led pathology supports translational research and clinical trials at every stage.

Speaker

Pierre Moulin, Diagnexia Analytix

Pierre Moulin, MD, PhD, MBA, CSO, Diagnexia Analytix

Dr. Pierre Moulin has established himself as a distinguished Physician-Scientist and Pathologist, with a specialist interest in the realms of data science and artificial intelligence in pathology. Dr. Moulin has hands-on experience in computational pathology, image analysis, deep learning and genomics analysis. He has held senior research positions in two of the top 10 pharmaceutical companies, where he made substantial contributions to enhancing clinical trials through his unique integration of molecular profiling, digital pathology, image analysis and artificial intelligence to improve the efficiency and precision of his pathology team.

Message Presenter

Who Should Attend?

This session will be particularly valuable for professionals involved in translational research, biomarker development and clinical trial operations, including:

  • Clinical Operations Leaders – overseeing trial delivery, timelines and vendor management
  • Biomarker & Translational Research Scientists – responsible for biomarker validation, assay development and data interpretation
  • Medical Directors & Clinical Development Teams – designing and running trials in oncology, immunology and other complex therapeutic areas
  • Pathology & Histology Leads – seeking scalable subspecialist support for study oversight and endpoint scoring
  • CRO Project Managers & Trial Coordinators – managing pathology workflows and ensuring regulator-ready outputs
  • Regulatory Affairs & Quality Specialists – focused on data reproducibility, compliance and audit-readiness
  • Biotech & Pharma Executives – driving strategy in precision medicine and trial innovation

What You Will Learn

Attendees will gain insight into:

  • How expert pathology leadership supports trial design and execution
  • The role of digital pathology in enabling faster turnarounds and global collaboration
  • Why pathology should be viewed as a strategic partner in drug development, not a bottleneck

Xtalks Partner

Diagnexia

Diagnexia combines world-class pathologist expertise with advanced quantitative capabilities to deliver bespoke, contextual insights for translational research and supporting clinical trials.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account